Skip to main content
. 2024 Jan 5;47(3):zsae001. doi: 10.1093/sleep/zsae001

Table 2.

Sleep-Related Characteristics of Final Sample

Sleep Regularity Groups
Variable Regular, N = 200 Mildly irregular, N = 2011 Severely irregular, N = 2011 P-value2
Sleep regularity index 84.8 (3.4) 76.1 (2.6) 61.9 (8.9) <0.001
PSG total sleep time (hours) 6.2 (0.9) 5.9 (0.9) 5.9 (1.0) 0.008
Actigraphy sleep duration (hours) 7.1 (0.7) 7.0 (0.8) 6.6 (1.3) <0.001
AHI (events/hour) 10.0 (10.6) 15.5 (17.1) 16.4 (18.1) <0.001
Time Spo2 < 90% saturation (min) 1.0 (3.4) 4.6 (16.5) 9.6 (38.2) 0.002
Sleep efficiency (%) 81.7 (17.4) 80.1 (21.5) 78.4 (14.5) 0.2
Sleep onset latency 69.4 (40.1) 78.1 (44.1) 73.7 (44.0) 0.13
Wake after sleep onset (min) 15.7 (16.4) 17.7 (18.1) 16.8 (18.6) 0.5
NREM (%) 80.3 (5.6) 81.9 (6.7) 82.3 (6.4) 0.003
N1 (%) 15.4 (7.6) 18.7 (12.4) 18.5 (10.8) 0.003
N2 (%) 50.3 (7.8) 48.4 (9.6) 49.5 (9.8) 0.10
N3 (%) 14.5 (8.0) 14.9 (9.4) 14.3 (9.2) 0.8
REM (%) 19.7 (5.6) 18.1 (6.7) 17.7 (6.4) 0.003
Insomnia symptoms (ISQ) 24 (12%) 29 (14%) 36 (18%) 0.2
Chronotype (MEQ) 0.002
Morning 90 (45%) 84 (42%) 70 (35%)
Evening 18 (9.0%) 31 (16%) 47 (24%)
Intermediate 92 (46%) 85 (42%) 81 (41%)
Unknown 0 1 3
Sleepiness (ESS) 15 (7.5%) 20 (10%) 17 (8.5%) 0.7
Unknown 0 1 1
Poor self-reported sleep quality (PSQI) 70 (35%) 76 (39%) 100 (51%) 0.003
Unknown 1 6 6

1Mean (SD).

2One-way ANOVA.

PSG, polysomnography; AHI, apnea hypopnea index; Sp02, oxygen saturation; T90, Time; SpO2, 90% saturation; NREM, non-rapid eye movement; N1, NREM stage 1; N2, NREM stage 2; N3, NREM stage 3; REM, rapid eye movement; ISQ, Insomnia Symptom Questionnaire; MEQ, “Morning Eveningness” Questionnaire; ESS, Epworth Sleepiness Scale; PSQI, Pittsburgh Sleep Quality Index.